|1.||Zimerson, Erik: 5 articles (09/2012 - 10/2006)|
|2.||Isaksson, Marléne: 5 articles (09/2012 - 10/2006)|
|3.||Bruze, Magnus: 4 articles (09/2012 - 10/2006)|
|4.||Tarskikh, M M: 3 articles (08/2013 - 12/2006)|
|5.||Lee, Ji-Sook: 3 articles (03/2013 - 03/2009)|
|6.||Yun, Chi-Young: 3 articles (03/2013 - 03/2009)|
|7.||Kim, In Sik: 3 articles (03/2013 - 03/2009)|
|8.||Goh, Chee-Leok: 3 articles (09/2012 - 07/2007)|
|9.||Henriks-Eckerman, Maj-Len: 3 articles (12/2010 - 02/2007)|
|10.||Kuuliala, Outi: 3 articles (12/2010 - 11/2007)|
11/23/2010 - "It was found that the long PEG segments were mostly segregated into the outer hydrophilic PEG layers of the vesicles, thereby providing active tumor targeting via FA, while the short PEG segments were mostly segregated into the inner hydrophilic PEG layer of the vesicles, thereby making it possible to cross-link the inner PEG layer via the acrylate groups for enhanced in vivo stability. "
04/01/2008 - "Consistent with the in vivo testing results, acrylic acid exhibited no evidence of carcinogenicity in chronic rodent cancer bioassays. "
12/01/2010 - "The long PEG segments bearing methoxy/folate groups (CH(3)O/FA-PEG(114)) were mostly segregated to the outer hydrophilic PEG layers of the wormlike vesicles thereby providing active tumor-targeting ability, while the short PEG segments bearing acrylate groups (PEG(46)-acrylate) were mostly segregated onto the inner hydrophilic PEG layers of the wormlike vesicles thereby allowing the inner PEG layers to be crosslinked via free radical polymerization for enhanced in vivo stability. "
07/01/2009 - "PPARgamma agonist DIM-Ph-4-CF(3), a template for RXRalpha agonist (E)-3-[5-di(1-methyl-1H-indol-3-yl)methyl-2-thienyl] acrylic acid: DIM-Ph-CF(3) is reported to inhibit cancer growth independent of PPARgamma and to interact with NR4A1. "
01/01/2012 - "In order to avoid anti-cancer drugs undergoing a first-pass effect and reduce their toxicity, and to solve conventional suppositories defects, we developed an in-situ-gelling and injectable Pluronic-poly(acrylic acid) (Pluronic-PAA) liquid suppository, which could gel fast in the physiological state and had suitable gel strength and bioadhesive force. "
|2.||Allergic Contact Dermatitis
09/01/2002 - "A new source of allergic contact dermatitis from UV-cured (meth)acrylate adhesive."
01/01/1993 - "This investigation was conducted after the occurrence of allergic contact dermatitis in three laboratory technicians all engaged in the production of UV-light-cured acrylate ear-moulds. "
10/01/2014 - "Acrylate-induced allergic contact dermatitis in a car windscreen repairer."
08/01/2013 - "We report a rare case of allergic contact dermatitis caused by isobornyl acrylate. "
09/01/2012 - "Atypical pattern of (meth)acrylate allergic contact dermatitis in dental professionals."
|3.||Human Influenza (Influenza)
01/01/2014 - "Synthesis and characterization of antigenic influenza A M2e protein peptide-poly(acrylic) acid bioconjugate and determination of toxicity in vitro."
05/01/2010 - "A polycation, N,N-dodecyl,methyl-polyethylenimine, with microbicidal activity was layered with a polyanion, such as poly(acrylic acid), to create LbL films highly effective against both airborne and waterborne Escherichia coli and Staphylococcus aureus (Gram negative and positive bacteria, respectively), as well as influenza A/WSN (H1N1) virus. "
05/17/2006 - "A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid."
04/01/1994 - "In this study, a series of poly(acrylic acid-co-acrylamides) and dextrans bearing pendant glycylamidobenzylsialoside groups were synthesized and evaluated for their binding to a panel of influenza A and B virus strains and for their ability to inhibit virus infectivity in cell culture. "
05/01/2005 - "The placebo and drug-loaded device of AxGx (acrylic acid:gelatin: 1:1 w/w) were employed for the treatment of experimental osteomyelitis in rabbit. "
05/01/2005 - "Efficacy of antibiotics-loaded interpenetrating network (IPNs) hydrogel based on poly(acrylic acid) and gelatin for treatment of experimental osteomyelitis: in vivo study."
|5.||Communicable Diseases (Infectious Diseases)
|4.||Anti-Bacterial Agents (Antibiotics)
|1.||Corneal Transplantation (Keratoplasty)